HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Novel Hemostatic Technology Controls Bleeding in All Cardiac Surgical Procedures

By HospiMedica International staff writers
Posted on 03 Aug 2023
Print article
Image: The QuikClot Control+ Hemostatic Device has received FDA clearance for an expanded indication (Photo courtesy of Teleflex)
Image: The QuikClot Control+ Hemostatic Device has received FDA clearance for an expanded indication (Photo courtesy of Teleflex)

A proprietary hemostatic technology specially developed for severe internal bleeding has received U.S. FDA clearance for expanded indications, allowing for its application across a broader patient population and a wider range of surgical procedures.

Teleflex Incorporated’s (Wayne, PA, USA) QuikClot Control+ Hemostatic Device has received FDA clearance to include mild and moderate bleeding in cardiac surgical procedures and bone surface bleeding after a sternotomy, enabling its use for the management of all forms of bleeding during cardiac surgeries by clinicians. Given that Teleflex research indicates over 600,000 open cardiothoracic procedures are conducted annually in the U.S., cardiothoracic and cardiovascular surgeons now have an additional tool to control intraoperative bleeding. The QuikClot Control+ Hemostatic Device has also received expanded intended usage to include patients on anticoagulation/antiplatelet medication, with or without the use of autotransfusion (blood salvage) equipment, and with or without cardiopulmonary bypass systems.

The FDA clearance comes after the successful completion and analysis of the 2021 cardiac investigational device exemption (IDE) study. This study focused on the percentage of patients who achieved hemostasis within the initial 10 minutes of hemostatic application and compression at the bleeding site, as well as safety outcomes. The study found that the QuikClot Control+ Hemostatic Device surpassed standard gauze in achieving clinical hemostasis for mild and moderate cardiac surgery bleeding, with no significant difference in safety outcomes. Patients treated with the QuikClot Control+ Hemostatic Device achieved hemostasis at a rate over 20% higher at both 5 and 10 minute intervals compared to those treated with standard gauze.

“We are excited to provide an additional tool to address bleeding control for cardiac surgeons,” said Kevin Robinson, President and General Manager, Anesthesia and Emergency Medicine Division, Teleflex. “We look forward to supporting positive patient outcomes in these procedures through the expanded use potential of our QuikClot Control+ Devices.”

Related Links:
Teleflex Incorporated

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Exam Table
PF400
Portable Jaundice Management Device
Nymphaea

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more